Description
CJC-1295 with DAC | Long-Acting GHRH Analog – Research Peptide
CJC-1295 with DAC is a synthetic analog of growth hormone-releasing hormone incorporating a Drug Affinity Complex, a maleimidoproprionic acid group that binds covalently to serum albumin.
Albumin conjugation substantially extends its circulating half-life relative to unmodified GHRH fragments. Research has examined its activity at the GHRH receptor and the pharmacokinetic consequences of albumin binding.
Common research applications: GHRH receptor binding studies, pharmacokinetic and half-life research, and growth hormone secretagogue model systems.
Specifications
| Compound | CJC-1295 with DAC |
|---|---|
| Quantity | 5mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is CJC-1295 with DAC?
CJC-1295 with DAC is a GHRH analog carrying a Drug Affinity Complex that binds serum albumin to extend its circulating half-life.
What is CJC-1295 with DAC studied for?
Research applications include GHRH receptor binding and pharmacokinetic studies of albumin-conjugated peptides. All work is laboratory research only.
What purity is CJC-1295 with DAC 5mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
📚 Research guide: Read our Sermorelin vs Ipamorelin vs CJC-1295: GHRH and Ghrelin Receptor Routes Compared
Research guide: Ipamorelin and CJC-1295 research overview
Reviews
There are no reviews yet.